Risk Factors for Retinal Hemorrhage after Photodynamic Therapy in Age-Related Macular Degeneration

November 26, 2008

Article

Please click here to read the full story.

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

A person stands in front of a white screen, facing an audience. The speaker and audience are visible in silhouette. Concept image for European Society of Retina Specialists (EURETINA) clinical trial data presentation. Logos courtesy of EURETINA, Ashvattha Therapeutics, Clearside Biomedical and Carl Zeiss Medical Technology. Background image courtesy of TezcanKemal, Getty Images. Created with Canva.

Ashvattha Therapeutics, Clearside Biomedical, ZEISS preview EURETINA presentations

Kassi Filkins

August 30th 2025

Article

PHOTON Results and Their Relation to DME Patients in Your Practice

August 30th 2025

Podcast

A person speaks on a stage during a conference/lecture. Concept image for 2025 EURETINA European Society of Retina specialists scientific meeting. Image credit: ©Anton Gvozdikov – stock.adobe.com

The Eye Care Network's clinical advisors will present at EURETINA

Hattie Hayes

August 30th 2025

Article

PULSAR Results and Their Relation to nAMD Patients in Your Practice

August 30th 2025

Podcast

$Concept image for the balancing of energy efficiency and time in refractive surgery phacoemulsification. A scale, with a laser beam of blue light on one side, and an analog alarm clock on the other side. The laser beam of blue light is surrounded by static. Created with Canva Magic AI.$